Eli Lilly loses UK Alimta patent case to Actavis

LONDON (Reuters) - Eli Lilly and Co LLY.N said on Thursday it lost a patent case in the English High Court over its blockbuster Alimta lung cancer drug to generic drugmaker Actavis Plc ACT.N.

Source: Reuters: Health - May 15, 2014 Category: Consumer Health News Tags: healthNews Source Type: news